HRP20160216T1 - Postupak za pripremu medetomidina s kloracetonom - Google Patents

Postupak za pripremu medetomidina s kloracetonom Download PDF

Info

Publication number
HRP20160216T1
HRP20160216T1 HRP20160216T HRP20160216T HRP20160216T1 HR P20160216 T1 HRP20160216 T1 HR P20160216T1 HR P20160216 T HRP20160216 T HR P20160216T HR P20160216 T HRP20160216 T HR P20160216T HR P20160216 T1 HRP20160216 T1 HR P20160216T1
Authority
HR
Croatia
Prior art keywords
reaction
compound
mixtures
group
reagent
Prior art date
Application number
HRP20160216T
Other languages
English (en)
Croatian (hr)
Inventor
Doerwald Florencio Zaragoza
Anna Kulesza
Stephan Elzner
Robert Bujok
Zbigniew Wrobel
Krzysztof Wojciechowski
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47557694&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20160216(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/070875 external-priority patent/WO2012172121A1/en
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of HRP20160216T1 publication Critical patent/HRP20160216T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20160216T 2012-06-28 2012-11-15 Postupak za pripremu medetomidina s kloracetonom HRP20160216T1 (hr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261665510P 2012-06-28 2012-06-28
EP12174102 2012-06-28
EP12188104 2012-10-11
PCT/EP2012/070875 WO2012172121A1 (en) 2012-06-28 2012-10-22 Method for the preparation of medetomidine with chloroacetone
EP12192625 2012-11-14
PCT/EP2012/072798 WO2013011157A1 (en) 2012-06-28 2012-11-15 Method for preparation of medetomidine with chloroacetone
EP12787007.9A EP2867211B1 (en) 2012-06-28 2012-11-15 Method for preparation of medetomidine with chloroacetone

Publications (1)

Publication Number Publication Date
HRP20160216T1 true HRP20160216T1 (hr) 2016-03-25

Family

ID=47557694

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160216T HRP20160216T1 (hr) 2012-06-28 2012-11-15 Postupak za pripremu medetomidina s kloracetonom

Country Status (20)

Country Link
US (2) US9156793B2 (enExample)
EP (1) EP2867211B1 (enExample)
JP (1) JP5777841B2 (enExample)
KR (1) KR101560116B1 (enExample)
CN (2) CN104245678B (enExample)
AU (1) AU2012285677B2 (enExample)
CA (1) CA2866437C (enExample)
CL (2) CL2014002907A1 (enExample)
CY (1) CY1117492T1 (enExample)
DK (1) DK2867211T3 (enExample)
EA (1) EA027921B1 (enExample)
ES (1) ES2565066T3 (enExample)
HR (1) HRP20160216T1 (enExample)
HU (1) HUE027382T2 (enExample)
IN (1) IN2014DN07984A (enExample)
MY (1) MY165218A (enExample)
PL (1) PL2867211T3 (enExample)
SG (1) SG11201405609WA (enExample)
TW (2) TWI560182B (enExample)
WO (1) WO2013011157A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2563816T3 (es) * 2012-05-08 2016-03-16 Lonza Ltd Método de preparación de medetomidina
IN2014DN07982A (enExample) 2012-05-08 2015-05-01 Lonza Ag
IN2014DN08121A (enExample) 2012-06-28 2015-05-01 Lonza Ag
SG11201405609WA (en) * 2012-06-28 2015-02-27 Lonza Ag Method for preparation of medetomidine with chloroacetone
EP3416341B1 (en) * 2016-02-12 2020-07-15 Sony Corporation Signalling of variable signal parameters
CN106518812A (zh) * 2016-10-25 2017-03-22 湖南大学 一种美托咪定及其中间体的制备方法
CN113044857B (zh) * 2020-12-30 2023-05-23 重庆柒兴克米科技有限公司 高收率制取高纯氰化钠或氰化钾的生产工艺
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE23400E (en) 1951-08-14 Electkic low and high-voltage fuses
BE790604A (fr) 1971-10-28 1973-04-26 Sandoz Sa Nouveaux aminoalcanols, leur preparation et leur application comme medicaments
JPS51100042A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
JPS51100041A (en) 1975-02-26 1976-09-03 Kanebo Ltd 22 * 44 isobuchirufueniru * puropionsanno seizoho
GB2092569B (en) 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE3586403T2 (de) 1984-02-24 1993-02-04 Sagami Chem Res Methode zum isomerisieren eines glycidats.
JPS62103037A (ja) * 1985-10-29 1987-05-13 Hamari Yakuhin Kogyo Kk ２−（４−イソブチルフエニル）−プロピオンアルデヒドの製造法
DE19714042A1 (de) 1997-04-05 1998-10-08 Henkel Kgaa Verfahren zur Herstellung aromatischer Aldehyde
SE513474C2 (sv) 1999-01-25 2000-09-18 Hans Elwing Instutionen Foer C Metod för att förhindra kräftdjurs, särskilt havstulpaners, etablering på fasta ytor med hjälp av en substans som stör nervsignaler, varvid substansen är medetomidin, dvs (+)-4-/1- (2,3-dimetylfenyl)-etyl/-IH-imidazol
EP1918282A1 (en) * 2006-11-06 2008-05-07 "Joint Stock Company Grindeks" Method for preparing medetomidine and its salts
GB2453982B (en) 2007-10-24 2009-09-16 Norbrook Lab Ltd Chemical process for the preparation of Medetomidine
US7902247B2 (en) 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
CN101921234B (zh) * 2009-06-12 2012-05-30 中国中化股份有限公司 一种制备美托咪啶的方法
WO2011070069A1 (en) * 2009-12-09 2011-06-16 I-Tech Ab Process for preparation of medetomidine
IN2014DN07982A (enExample) * 2012-05-08 2015-05-01 Lonza Ag
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
ES2563816T3 (es) 2012-05-08 2016-03-16 Lonza Ltd Método de preparación de medetomidina
WO2012172120A2 (en) 2012-05-08 2012-12-20 Lonza Ltd 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume
IN2014DN08121A (enExample) 2012-06-28 2015-05-01 Lonza Ag
SG11201405609WA (en) * 2012-06-28 2015-02-27 Lonza Ag Method for preparation of medetomidine with chloroacetone
WO2012172121A1 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of medetomidine with chloroacetone
WO2012172122A2 (en) * 2012-06-28 2012-12-20 Lonza Ltd Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal

Also Published As

Publication number Publication date
TWI543970B (zh) 2016-08-01
CA2866437A1 (en) 2013-01-24
DK2867211T3 (en) 2016-02-29
CA2866437C (en) 2018-01-02
EA201400939A1 (ru) 2015-01-30
US20150099889A1 (en) 2015-04-09
JP2015517474A (ja) 2015-06-22
IN2014DN07984A (enExample) 2015-05-01
HUE027382T2 (en) 2016-10-28
WO2013011157A1 (en) 2013-01-24
PL2867211T3 (pl) 2016-06-30
CN104245678A (zh) 2014-12-24
US20150336909A1 (en) 2015-11-26
US9156793B2 (en) 2015-10-13
US9434694B2 (en) 2016-09-06
CN104245678B (zh) 2016-02-24
CL2016001664A1 (es) 2017-01-27
TW201402553A (zh) 2014-01-16
SG11201405609WA (en) 2015-02-27
HK1213893A1 (zh) 2016-07-15
KR20140129399A (ko) 2014-11-06
CL2014002907A1 (es) 2015-01-16
TW201630888A (zh) 2016-09-01
EP2867211A1 (en) 2015-05-06
MY165218A (en) 2018-03-09
TWI560182B (en) 2016-12-01
EA027921B1 (ru) 2017-09-29
CN105218453A (zh) 2016-01-06
JP5777841B2 (ja) 2015-09-09
EP2867211B1 (en) 2015-12-30
KR101560116B1 (ko) 2015-10-13
HK1201530A1 (zh) 2015-09-04
ES2565066T3 (es) 2016-03-31
AU2012285677A1 (en) 2014-09-25
CY1117492T1 (el) 2017-04-26
CN105218453B (zh) 2017-04-12
AU2012285677B2 (en) 2016-03-31
NZ700642A (en) 2016-04-29

Similar Documents

Publication Publication Date Title
HRP20160216T1 (hr) Postupak za pripremu medetomidina s kloracetonom
HRP20160215T1 (hr) Postupak za pripravu medetomidina
CN102876462B (zh) 一种制备高品质环氧大豆油的方法
CN101982453B (zh) 一种磺酸型离子液体促进下尼泊金酯类化合物的制备方法
US20120016141A1 (en) Method and apparatus for preparing hydroxymethylfurfural
CN103073535B (zh) 一种吡虫啉的合成方法
EP2631253A3 (en) Preparation of polymer, resulting polymer, resist composition, and patterning process
CN104774154A (zh) 超强碱离子液体催化醇解聚对苯二甲酸乙二醇酯的方法
CN112939799A (zh) 一种n-羟甲基丙烯酰胺的合成方法
CN104262285A (zh) 农用杀虫剂茚虫威中间体的合成法
CN102329233B (zh) 离子液体作用下催化合成对苯二甲酸二异辛酯的方法
CN102001948B (zh) 一种酯化合成对苯二甲酸二异辛酯的方法
CN104292187B (zh) 一种制备高品质环氧大豆油的方法
CN103224837B (zh) 一种快速、绿色制备环氧化大豆油的方法
CN103252239B (zh) 一种合成甘油碳酸酯的催化剂及制备方法和应用
CN104448547A (zh) 一种防虫防腐塑料片材
CN103304415A (zh) 一种制备马来酸二异丙酯的方法
CN103664584B (zh) a-氟代丙酰乙酸酯的制备方法
CN105330623A (zh) 无机盐催化合成5-羟甲基糠醛的方法
CN106083585B (zh) 一种间接醇解制备碳酸二甲酯的方法
CN102731250A (zh) 一种合成仲丁醇的方法
CN104177296B (zh) 一种4-(1-羟基-1-甲基乙基)-2-丙基-1h-咪唑-5-羧酸乙酯的制备方法
CN108129300A (zh) 一种乙酰水杨酸的制备新方法
CN102675120A (zh) 一种固体酸催化剂应用于3,4-二氯硝基苯的制备
CN102659697A (zh) 一种节能环保的三氮唑钠制备方法